Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bronchial Disease”

13,678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 13,678 results

Testing effectiveness (Phase 2)UnknownNCT03848611
What this trial is testing

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small Cell Lung Cancer
AnewPharma 20
Not applicableUnknownNCT05738044
What this trial is testing

Multi-omics Studies of Host-microbiome Interaction in Chronic Obstructive Pulmonary Disease and Bronchiectasis

Who this might be right for
COPD ExacerbationBronchiectasis With Acute Exacerbation
Ruijin Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00684099
What this trial is testing

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 70
Not applicableLooking for participantsNCT06833632
What this trial is testing

Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Large-scale testing (Phase 3)Study completedNCT02813785
What this trial is testing

Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 565
Testing effectiveness (Phase 2)Looking for participantsNCT06485544
What this trial is testing

Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Who this might be right for
Small Cell Lung Cancer (SCLC)
Tang-Du Hospital 104
Testing effectiveness (Phase 2)Study completedNCT01591044
What this trial is testing

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Who this might be right for
Asthma
Rigel Pharmaceuticals 301
Not applicableStudy completedNCT00005134
What this trial is testing

Strong Heart Study

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis+7 more
National Heart, Lung, and Blood Institute (NHLBI)
Post-approval studies (Phase 4)Study completedNCT00452699
What this trial is testing

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma

Who this might be right for
Asthma
GlaxoSmithKline 621
Early research (Phase 1)UnknownNCT05021887
What this trial is testing

A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Who this might be right for
AsthmaBioequivalence
Respirent Pharmaceuticals Co Ltd. 50
Not applicableStudy completedNCT01662635
What this trial is testing

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)

Who this might be right for
Non Small-cell Lung Cancer
Instituto Nacional de Cancerologia de Mexico 230
Early research (Phase 1)Ended earlyNCT02309892
What this trial is testing

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Helix BioPharma Corporation 14
Testing effectiveness (Phase 2)Ended earlyNCT01857271
What this trial is testing

Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 3
Post-approval studies (Phase 4)UnknownNCT00597064
What this trial is testing

Inflammatory, Functional and Image Composite Measure to Define Asthma Control

Who this might be right for
Asthma
Federal University of São Paulo 70
Not applicableLooking for participantsNCT04784364
What this trial is testing

Biologics And Clinical Immunology Cohort at Sinai

Who this might be right for
Immunological DiseaseAutoimmune DiseasesPrimary Immune Deficiency
Icahn School of Medicine at Mount Sinai 800
Testing effectiveness (Phase 2)Study completedNCT05509699
What this trial is testing

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Hutchison Medipharma Limited 21
Post-approval studies (Phase 4)Study completedNCT02233985
What this trial is testing

Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants

Who this might be right for
BronchiolitisWheezing
Coordinación de Investigación en Salud, Mexico 64
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Not applicableStudy completedNCT00960271
What this trial is testing

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
University Hospital, Rouen 363
Not applicableActive Not RecruitingNCT01969344
What this trial is testing

Study of COPD Subgroups and Biomarkers

Who this might be right for
COPDChronic Obstructive Pulmonary DiseaseChronic Bronchitis+1 more
University of North Carolina, Chapel Hill 2,981
Load More Results